Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 18,121 | 20,954 | 37,973 | 28,393 | 25,726 |
| Operating Income | -18,121 | -20,954 | -37,973 | -28,393 | -25,726 |
| Other Income | 2,220 | 1,711 | 1,872 | 719 | 164 |
| Pre-tax Income | -15,901 | -19,243 | -36,101 | -27,674 | -25,562 |
| Net Income Continuous | -15,901 | -19,243 | -36,101 | -27,674 | -25,562 |
| Net Income | $-15,901 | $-19,243 | $-36,101 | $-27,674 | $-25,562 |
| EPS Basic Total Ops | -0.41 | -0.54 | -1.04 | -0.85 | -0.79 |
| EPS Basic Continuous Ops | -0.41 | -0.54 | -1.05 | -0.85 | -0.79 |
| EPS Diluted Total Ops | -0.41 | -0.54 | -1.04 | -0.85 | -0.79 |
| EPS Diluted Continuous Ops | -0.41 | -0.54 | -1.05 | -0.85 | -0.79 |
| EBITDA(a) | $-18,857 | $-21,371 | $-37,781 | $-28,193 | $-25,567 |